Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Cash from Financing Activities (2024 - 2025)

Profound Medical has reported Cash from Financing Activities over the past 2 years, most recently at $41.4 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $41.4 million for Q4 2025, up 16.91% from a year ago — trailing twelve months through Dec 2025 was $41.1 million (down 24.79% YoY), and the annual figure for FY2025 was $41.1 million, down 24.79%.
  • Cash from Financing Activities for Q4 2025 was $41.4 million at Profound Medical, up from -$290000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for PROF hit a ceiling of $41.4 million in Q4 2025 and a floor of -$603000.0 in Q2 2024.